Search results for : ntrk3 - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
AZD1332	SN1061387896	NTRK1, NTRK2, NTRK3	RTK signaling		GDSC1	919	SANGER
AZD1332	SN1061387896	NTRK1, NTRK2, NTRK3	RTK signaling		GDSC2	717	SANGER
Lestaurtinib	CEP-701, SP-924, SPM-924, A-154475, KT-555	FLT3, JAK2, NTRK1, NTRK2, NTRK3	Other, kinases	126565	GDSC1	929	SANGER
Lestaurtinib	CEP-701, SP-924, SPM-924, A-154475, KT-555	FLT3, JAK2, NTRK1, NTRK2, NTRK3	Other, kinases	126565	GDSC2	947	SANGER

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer

Search Results for: ntrk3